HomeFDMT • NASDAQ
add
4D Molecular Therapeutics Inc
Previous close
$11.19
Day range
$10.67 - $11.50
Year range
$2.24 - $12.34
Market cap
611.35M USD
Avg Volume
961.46K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 90.00K | 2,900.00% |
Operating expense | 11.84M | -6.43% |
Net income | -56.88M | -29.73% |
Net profit margin | -63.20K | 95.68% |
Earnings per share | -1.01 | -27.85% |
EBITDA | -57.72M | -15.58% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 305.06M | -39.22% |
Total assets | 423.98M | -29.81% |
Total liabilities | 55.00M | 7.67% |
Total equity | 368.98M | — |
Shares outstanding | 57.14M | — |
Price to book | 1.42 | — |
Return on assets | -32.86% | — |
Return on capital | -35.31% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -56.88M | -29.73% |
Cash from operations | -46.50M | -58.20% |
Cash from investing | 17.78M | -34.88% |
Cash from financing | 116.00K | -79.58% |
Net change in cash | -28.60M | -1,779.37% |
Free cash flow | -25.05M | -61.05% |
About
Founded
2013
Headquarters
Website
Employees
227
